Header Logo

Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs.

Al Rifai M, Mahtta D, Ramsey DJ, Lee MT, Krittanawong C, Navaneethan SD, Gregg LP, Petersen LA, Virani SS. Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs. Am Heart J. 2022 06; 248:160-162.

View in: PubMed